Loblaw said a boycott of its stores during its latest quarter had a minimal impact, as the company attributed lower profits to a settlement over an alleged bread price-fixing scheme.
Loblaw attributed that in part to the company's strong performance a year earlier, making it a tough comparison. Regarding the boycott, “we did notice a bit of an impact in certain stores in specific markets, but that said, at the end of the quarter, things have returned to normal,” said Dufresne. Drug retail same-store sales increased 1.5 per cent, with front store same-store sales down 2.4 per cent and pharmacy and health-care services same-store sales up 5.4 per cent.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: